Challenges and Considerations of Preclinical Development for iPSC-Based Myogenic Cell Therapy
Cell therapies derived from induced pluripotent stem cells (iPSCs) offer a promising avenue in the field of regenerative medicine due to iPSCs’ expandability, immune compatibility, and pluripotent potential. An increasing number of preclinical and clinical trials have been carried out, exploring the...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI AG
2024-03-01
|
| Schriftenreihe: | Cells |
| Schlagworte: | |
| Online-Zugang: | https://www.mdpi.com/2073-4409/13/7/596 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|